Prognostic molecular markers for ET743 treatment

Details for Australian Patent Application No. 2008313634 (hide)

Owner PHARMA MAR, S.A.

Inventors Jimeno Donaque, Jose M.; Rosell Costa, Rafael; Taron Roca, Miguel; Tercero Lopez, Juan Carlos; Martinez Magunacelaya, Nerea; Diez Rodriguez, Ana

Agent Collison & Co

Pub. Number AU-A-2008313634

PCT Pub. Number WO2009/050303

Priority 07380282.9 19.10.07 EP

Filing date 20 October 2008

Wipo publication date 23 April 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/050303 Priority application(s): WO2009/050303

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008313636-Production system for electric energy and hydrogen

2008313627-Improved antitumoral treatments